Skip to main content

Table 2 Treatment related adverse events

From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

 

No. of Patients (n = 42)

 

Grade I

Grade II

Grade III

Grade IV

Haematological

    

   Anaemia

3 (7.1%)

1 (2.4%)

-

-

   Neutropenia

5 (11.9%)

4 (9.5%)

3 (7.1%)

1 (2.4%)

Neuropathy

5 (11.9%)

6 (14.3)

3 (7.1%)

-

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us